Analyst Ratings For Cigna
Within the last quarter, Cigna (NYSE:CI) has observed the following analyst ratings:
Cigna Has Limited Visibility, No Bullish Catalysts, BofA Says In Double Downgrade
Cigna Corp (NYSE: CI) shares were losing ground Friday after the stock was hit by a Wall Street double downgrade.
The Cigna Analyst: Bank of America analyst Kevin Fischbeck downgraded Cigna from Buy to Underperform and cut the price target from $240 to $225.
8 Health Care Stocks With Unusual Options Alerts In Today’s Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Unusual trading activity could push option prices to exaggerated or underestimated levels.
B of A Securities Downgrades Cigna to Underperform, Lowers Price Target to $225
B of A Securities analyst Kevin Fischbeck downgrades Cigna (NYSE:CI) from Buy to Underperform and lowers the price target from $240 to $225.
Tenet and Cigna Extend and Expand Network Access, Effective Jan. 1, 2022
Multi-year agreement provides Cigna customers with continued in-network access to Tenet providers through 2025
Tenet Healthcare Corporation (NYSE:THC) and Cigna Corporation (NYSE:CI) today announced that they have
Cigna Says Reached Agreement With Hartford HealthCare To Keep Quality Care Affordable, Effective Nov. 1, 2021
Cigna (NYSE:CI) and Hartford HealthCare have reached a multi-year agreement that ensures Cigna customers will have continued access to Hartford HealthCare's hospitals, facilities and providers for quality care at
Cigna 8-K Shows Co. To Meet With Investors, Analysts Over Next Several Weeks, Will Reaffirm FY21 Adj. EPS Guidance At Least $20.20, FY22 Adj. EPS Growth At Least 10% Year Over Year
Cigna Corporation (“Cigna” or the “Company”) officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, Cigna officials
Morgan Stanley Maintains Overweight on Cigna, Lowers Price Target to $275
Morgan Stanley analyst Craig Hettenbach maintains Cigna (NYSE:CI) with a Overweight and lowers the price target from $321 to $275.
5 Value Stocks In The Healthcare Sector
The Meaning Behind Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.